Renal Cell Carcinoma
Latest News
Cancer care and COVID-19 in Seattle, the first U.S. epicenter
Feature
How is oncology adapting to COVID-19?
Feature
Disruptions in cancer care in the era of COVID-19
Conference Coverage
Lymphopenia linked to worse response in RCC, bladder cancer patients on checkpoint inhibitors
ORLANDO – Patients with lower pretreatment absolute lymphocyte counts and higher neutrophil-lymphocyte ratios were less likely to respond to...
Conference Coverage
Largest meeting on cancer research canceled: AACR
From the Journals
Bevacizumab/pembrolizumab deemed safe and active in mRCC
The combination produced responses in 42% of relapsed/refractory patients and 61% of previously untreated patients.
From the Journals
Tumor neoantigenicity metric improves prediction of response to immunotherapy
A new scoring system can predict response to immunotherapy in patients with melanoma, lung cancer, and kidney cancer.
From the Journals
Late effects in young cancer survivors underscore importance of high-risk screening
Childhood cancer survivors have higher standardized mortality ratios than early-adolescent and young adult cancer survivors.
Conference Coverage
SBRT may boost efficacy of immunotherapy in renal cell carcinoma
SAN FRANCISCO – More than half of patients in the RADVAX RCC trial had a response in nonirradiated lesions, but the prespecified threshold for...
From the Journals
Shorter time to metastases associated with worse RCC outcomes
Synchronous disease a distinct molecular phenotype?
News
FDA: Cell phones still look safe
The available evidence does not suggest a causal link between cell phone use and cancer, according to the FDA.